MIACALCIN® (calcitonin-salmon) Nasal Spray is an effective therapy…

Because It Works

	Stops bone loss and significantly increases bone mineral density
	No serious drug-related GI or menopausal side effects
	Just one spray, once a day—anytime, anywhere

Because It's Safe, Convenient, and Tolerable for Many Patients

	With GI problems
	With limited mobility
	With renal impairment
	Taking multiple medications
	Who are unable to follow complicated daily or weekly dosing instructions

MIACALCIN Nasal Spray is indicated for the treatment of postmenopausal osteoporosis in women greater than 5 years postmenopause with low bone mass who refuse or cannot tolerate estrogens, or in whom estrogens are contraindicated. Patients should ensure adequate calcium and vitamin D intake.

Rhinitis, other nasal symptoms, back pain, arthralgia, epistaxis, and headache were the most common adverse events. Because calcitonin-salmon is a protein, the potential for a systemic allergic reaction exists. In rare cases, nasal ulcerations were reported that required temporary discontinuation of therapy until healing occurred.

For further information, please consult the complete Prescribing Information.

Home | Professional Main Page | Treatment Guidelines
MIACALCIN Nasal Spray | Patient Challenges | Patient Education
Resources | Prescribing Information